Hemophilia Patient Panel
Connecting Qualified Patients for Hemophilia Research and Clinical Studies
Our hemophilia patient panel connects healthcare organizations with qualified patients to support clinical research and market studies. MedPanel provides reliable access to participants, enabling accurate insights and improved healthcare outcomes.
We have access to one of the largest databases in the US bleeding disorder community; about 4,000 families through a partnership with LA Kelley Communications, Inc. This highly curated custom database of patients and caregivers has been built over 30 years. We also have access to key opinion leaders at the hemophilia treatment centers worldwide. Some of the patient data includes diagnoses, severity level, birth dates, inhibitors, and email and post addresses.
Our hemophilia patient panel connects healthcare organizations with qualified patients to support clinical research and market studies. Additionally, MedPanel provides reliable access to participants, enabling accurate insights and improved healthcare outcomes.
First, we identify eligible patients through targeted outreach and curated networks. Next, we conduct detailed screening to ensure participants meet study-specific requirements. Finally, we manage engagement and participation to support smooth research execution
Moreover, our hemophilia patient panel supports both clinical and market research initiatives. As a result, organizations can gather reliable insights and accelerate decision-making.
However, hemophilia research often requires access to specialized patient populations. Therefore, our panel plays a critical role in supporting studies focused on treatment outcomes and patient experiences.
LA Kelley Communications, Inc. announces a new partnership with MedPanel, Inc. to provide in-depth market research in the bleeding disorder community.
If you have a request for a bleeding disorder project, please click on this link and tell us about your requirements:
https://
